Celsion Corp (CLSN) - Financial and Strategic SWOT Analysis Review

November 2021 | 50 pages | ID: C1AFA4FFDF9EN
GlobalData

Abstracts

Celsion Corp (CLSN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

• Business description – A detailed description of the company’s operations and business divisions.
• Corporate strategy – Analyst’s summarization of the company’s business strategy.
• SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
• Company history – Progression of key events associated with the company.
• Major products and services – A list of major products, services and brands of the company.
• Key competitors – A list of key competitors to the company.
• Key employees – A list of the key executives of the company.
• Executive biographies – A brief summary of the executives’ employment history.
• Key operational heads – A list of personnel heading key departments/functions.
• Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
• Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
• Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Celsion Corp (Celsion) is an oncology company with focus on developing portfolio of new cancer treatments, including directed chemotherapies, RNA and DNA based therapies and immunotherapies. The company develops drugs using its’s three platform technologies including Lysolipid Thermally Sensitive Liposomes (LTSL), TheraPlas and TheraSilence. Its lead product candidate ThermoDox is a proprietary form of doxorubicin based LTSL technology in Phase III clinical trial for the treatment of primary liver cancer. It is also developing a comprehensive pipeline of targeted therapeutic agents for cancer. Celsion is headquartered in Lawrenceville, New Jersey, the US.

Celsion Corp Key Recent Developments

Nov 15,2021: Celsion Reports Third Quarter 2021 Financial Results
Sep 17,2021: Celsion and Hainan Poly Pharm sign agreement to manufacture Celsion’s DNA-based Vaccine
Aug 12,2021: Celsion Reports Second Quarter 2021 Financial Results and Provides Business Update
Jul 15,2021: Celsion expands vaccine advisory board with the addition of Dr. Dan H. Barouch and Dr. Luke D. Handke
Jun 21,2021: Celsion Corp. Enters into $10 Million Strategic Loan Facility with Silicon Valley Bank

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

• The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

• The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

• Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.

• Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

• Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Contents

SECTION 1 - ABOUT THE COMPANY

Celsion Corp - Key Facts
Celsion Corp - Key Employees
Celsion Corp - Key Employee Biographies
Celsion Corp - Major Products and Services
Celsion Corp - History
Celsion Corp - Company Statement
Celsion Corp - Locations And Subsidiaries
Head Office

SECTION 2 – COMPANY ANALYSIS

Company Overview
Celsion Corp - Business Description
Celsion Corp - SWOT Analysis
SWOT Analysis - Overview
Celsion Corp - Strengths
Celsion Corp - Weaknesses
Celsion Corp - Opportunities
Celsion Corp - Threats
Celsion Corp - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Celsion Corp, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Celsion Corp, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Celsion Corp, Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

Nov 15, 2021: Celsion Reports Third Quarter 2021 Financial Results
Sep 17, 2021: Celsion and Hainan Poly Pharm sign agreement to manufacture Celsion’s DNA-based Vaccine
Aug 12, 2021: Celsion Reports Second Quarter 2021 Financial Results and Provides Business Update
Jul 15, 2021: Celsion expands vaccine advisory board with the addition of Dr. Dan H. Barouch and Dr. Luke D. Handke
Jun 09, 2021: Celsion Appoints Christine A. Pellizzari to its Board of Directors
Jun 08, 2021: Celsion Corporation Appoints Dr. Stacy R. Lindborg to its Board of Directors
Jun 04, 2021: Celsion Corp. Announces Adjournment of Annual Meeting
May 27, 2021: Celsion Urges All Shareholders to Vote at the 2021 Annual Meeting to be Held on Friday June 4, 2021
May 14, 2021: Celsion Corporation Reports First Quarter 2021 Financial Results and Provides Business Update
May 07, 2021: Celsion to Hold First Quarter 2021 Financial Results and Business Update Conference Call on Friday, May 14, 2021

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List Of Tables

LIST OF TABLES

Celsion Corp, Key Facts
Celsion Corp, Key Employees
Celsion Corp, Key Employee Biographies
Celsion Corp, Major Products and Services
Celsion Corp, History
Celsion Corp, Key Competitors
Celsion Corp, Ratios based on current share price
Celsion Corp, Annual Ratios
Celsion Corp, Annual Ratios (Cont...1)
Celsion Corp, Interim Ratios
Celsion Corp, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Celsion Corp, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Celsion Corp, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List Of Figures

LIST OF FIGURES

Celsion Corp, Performance Chart (2016 - 2020)
Celsion Corp, Ratio Charts
Celsion Corp, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Celsion Corp, Pharmaceuticals & Healthcare, Deals by Type, 2015 to YTD 2021